share_log

兄弟科技(002562.SZ):制剂主要聚焦神经、代谢、免疫、呼吸等治疗领域进行产品研发工作

Brother Enterprises Holding (002562.SZ) mainly focuses on research and development of products in the areas of neurology, metabolism, immunology, and respiration for formulation.

Gelonghui Finance ·  Jul 2 05:11

On July 2nd, Gelunhui reported that investors asked Brother Enterprises Holding (002562.SZ) on the investor interactive platform whether the company has rare disease drugs or is developing such drugs. The company replied that their formulations mainly focus on product research and development in the fields of nervous system, metabolism, immune system, and respiratory system. Currently there are no rare disease drugs.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment